Hudson Bay Capital Management LP Eli Lilly & CO Put Options Transaction History

Hudson Bay Capital Management LP

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $239 Million - $298 Million	-310,000 Reduced 79.49%	80,000 $70.9 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $268 Million - $336 Million	370,000 Added 1850.0%	390,000 $353 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $11.8 Million - $15.8 Million	20,000 New	20,000 $15.6 Million

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.